ZURICH (Reuters) - Swiss pharmaceuticals giant Novartis named Marie-France Tschudin head of its main drugs business after its previous manager, Paul Hudson, was poised to take the CEO position at French drugmaker Sanofi (PA:SASY).
Tschudin, a Swiss citizen who speaks six languages, joined Novartis in 2017 after previously working at Celgene (NASDAQ:CELG). She becomes president of Novartis Pharmaceuticals immediately.